Immuron Limited (AU:IMC) has released an update.
Immuron Limited reports a significant revenue increase of 171.7% for the fiscal year ending June 30, 2024, mainly from strong Travelan sales in Australian, U.S., and North American markets. Despite this, the company experienced an 83.2% rise in net losses, attributed to substantial investments in research and development, which were partially offset by R&D grants. No dividends were issued, and the company’s cash position remains solid at $11.7 million.
For further insights into AU:IMC stock, check out TipRanks’ Stock Analysis page.
